Navigation Links
Lilly Declares Fourth-Quarter 2013 Dividend
Date:10/21/2013

INDIANAPOLIS, Oct. 21, 2013 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2013 of $0.49 per share on outstanding common stock.

The dividend is payable December 10, 2013 to shareholders of record at the close of business on November 15, 2013.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information – for some of the world's most urgent medical needs.  Additional information about Lilly is available at www.lilly.com.  F-LLY

Refer to: (317) 276-5795 Mark Taylor

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Lilly Reintegration Scholarship Applications Available for 2014-2015 Academic Year
2. Lilly to host investment community meeting at its Indianapolis headquarters on Thursday, October 3, 2013
3. Data Presented at 49th EASD Annual Meeting Show Treatment with Lillys Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes
4. Lilly Announces Second Positive Ramucirumab Phase III Gastric Cancer Study Meets Primary Endpoint; Phase III Lilly/TRIO Breast Cancer Study Misses Primary Endpoint
5. Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome Blood-Based Biomarker Discovery
6. Lilly to Present Data Across its Diabetes Portfolio at the 49th European Association for the Study of Diabetes Annual Meeting
7. Humana and Lilly Form Research Collaboration to Improve Health Care Outcomes
8. Dr. Marschall S. Runge Elected to Lilly Board of Directors
9. Lilly Reports Second-Quarter 2013 Results
10. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
11. Lilly Disappointed in Draft Medicare Coverage Decision for Beta-Amyloid Imaging Agents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... April 27, 2015  Agena Bioscience today announced Bioyong Technology ... MassARRAY platform in China . ... is a hotbed for practical, meaningful innovations that are improving ... for the rest of the world. We are proud to ... China ," said Peter Dansky , Agena Bioscience,s ...
(Date:4/27/2015)... Endo International plc (NASDAQ: ENDP ) (TSX: ENL) will ... of the U.S. financial markets on May 11, 2015 and ... call and webcast at 9:00 a.m. ET that day.  ... U.S./ Canada (866) 497-0462, International (678) 509-7598, ... minutes prior to the scheduled start time. A ...
(Date:4/26/2015)... , April 26, 2015 Cancer experts ... VAR ) supported project in the area of distributed ... data" for the benefit of patients. Speakers at a ... Society for Therapeutic Radiation Oncology) forum in Barcelona ... treatment and applying that knowledge to help benefit the ...
Breaking Medicine Technology:Agena Bioscience Names Bioyong Technology as Fifth Certified Service Provider in China 2Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 2Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 3
... Wis., Sept. 12, 2011 ... with facilities in the US and China, and Spaulding ... ECG Core Lab, and Medical Device Manufacturer have entered ... partnership establishes a global footprint by combining Frontage,s presence ...
... PRINCETON, N.J., Sept. 12, 2011 Covance Inc. (NYSE: ... the Morgan Stanley Global Healthcare Conference on Wednesday, ... a live webcast of the presentation at www.covance.com . ... log on 10 minutes early. Covance, with headquarters ...
Cached Medicine Technology:Spaulding Clinical Announces New Strategic Partnership With Frontage Laboratories, Inc. 2Spaulding Clinical Announces New Strategic Partnership With Frontage Laboratories, Inc. 3Covance to Present at Morgan Stanley Global Healthcare Conference 2
(Date:4/27/2015)... Ticket Down is a reputable source ... Valley Music Theatre and the Isleta Amphitheater. ... Mexico area can celebrate because their favorite performer will ... Buffett will be performing alongside legendary performers, Huey Lewis ... during the summer and fall months of 2015 are ...
(Date:4/27/2015)... April 27, 2015 Telematics Berlin is ... 1&2 suppliers, associations, CE players and the government to ... opened to the car. This year’s panel on connected ... at the European Commission, is an opportunity to hear ... define a European Automotive Security Standard for years to ...
(Date:4/27/2015)... The global coagulation analyzers market is ... developed countries; however, it is expected to witness ... India and Brazil in the next five years. ... by factors such as increasing adoption of automated ... hemostasis analyzers, developments in high-sensitivity point-of-care coagulation analyzers ...
(Date:4/27/2015)... April 27, 2015 Attorney Dan Newlin, of ... serving and protecting his clients, took that commitment to a ... dialing code which makes it easier for existing and potential ... on building his brand and added value to the firm’s ... Chicago area where Newlin has law offices. , “I knew ...
(Date:4/27/2015)... Volpara Solutions today announced the release ... of Breast Imaging’s SBI/ACR Breast Imaging Symposium in ... VolparaDensity, the first breast density assessment tool ... datasets from multiple manufacturers, is already in use ... , The latest version of VolparaDensity ...
Breaking Medicine News(10 mins):Health News:Cheap Jimmy Buffett Tickets at Alpine Valley Music Theatre in Elkhorn, WI and at Isleta Amphitheater in Albuquerque, NM Now on Sale at TicketDown.com 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 3Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 3Health News:Dan Newlin Hashtags It With #Dan 2Health News:Volpara Solutions Releases VolparaDensity 3.1 for Use with Tomosynthesis Systems from Multiple Manufacturers at SBI 2Health News:Volpara Solutions Releases VolparaDensity 3.1 for Use with Tomosynthesis Systems from Multiple Manufacturers at SBI 3
... available in French . , ,Hamilton, ... today announced a new study that will increase the ... Member of Parliament for Ancaster-Dundas-Flamborough-Westdale, made the announcement on ... , "This long-term study of 50,000 Canadians will look ...
... Steinem,s 75th Birthday NEW YORK, May 21 ... will be joined by prominent members of the ... of its co-founder Gloria Steinem,s 75th birthday and ... tribute to grassroots women activists and philanthropists who ...
... May 21 Advana Science ( www.advanascience.com ) ... Alzheimer,s disease, has been named scientific advisor to the Company. ... (Volume 16, Issue 3), Dr. Smith was ranked third in ... March 2009. Dr. Smith brings over 20 years of ...
... Most of the current obesity research is not proving ... according to a Deakin University public health expert. , ... better directed at testing possible solutions rather than continuing ... , "It seems counter intuitive, but knowing the causes ...
... The Technology Alliance, UW TechTransfer all partners in ... leaders in health care, business, and community advocacy ... Partnership to Fight Chronic Disease (PFCD). Richard ... General (2002-2006), President of the nonprofit Canyon Ranch ...
... Efficacy Rates in Patients with Challenging Anatomy Consistent ... May 21 New data presented today at ... that Abbott,s market-leading XIENCE V(R) Everolimus Eluting Coronary ... (target lesion revascularization), stent thrombosis and major adverse ...
Cached Medicine News:Health News:Government of Canada supports research to improve the health of future generations of Canadians 2Health News:The Ms. Foundation for Women's 21st Annual Gloria Awards: A National Salute to Women of Vision 2Health News:The Ms. Foundation for Women's 21st Annual Gloria Awards: A National Salute to Women of Vision 3Health News:The Ms. Foundation for Women's 21st Annual Gloria Awards: A National Salute to Women of Vision 4Health News:Leading Alzheimer's Disease Researcher Mark A. Smith, PhD Named Scientific Advisor at Advana Science 2Health News:Leading Alzheimer's Disease Researcher Mark A. Smith, PhD Named Scientific Advisor at Advana Science 3Health News:New direction needed for obesity research, Deakin health expert claims 2Health News:Technology Leaders, Patient Groups and Community Advocates Launch Effort to Tackle Chronic Disease Crisis in Washington State 2Health News:Technology Leaders, Patient Groups and Community Advocates Launch Effort to Tackle Chronic Disease Crisis in Washington State 3Health News:Technology Leaders, Patient Groups and Community Advocates Launch Effort to Tackle Chronic Disease Crisis in Washington State 4Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 2Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 3Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 4Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 5Health News:Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study 6
... provides optimum flow rate for ... on any voltage worldwide. Optical ... Interlock and easy load head. ... Spike Tubing, Dual Pneumatic Foot ...
... Device uses a 2-mm reciprocating movement at 4000 ... the cannula in tissue. So less force is ... That makes the lipoplasty procedure easier on both ... to learn that the PAL® is not ultrasonic. ...
... The next generation of ... new PSI-TEC III retains all ... made PSI-TEC a leading name ... maximum flow,vacuum pumps for high ...
Richardson Blade - for use with Bookler Universal Table Mounted Retractor Systems...
Medicine Products: